导管抽栓联合置管溶栓与单纯置管溶栓治疗 急性肺栓塞的疗效对比及预测模型构建
Comparison of Efficacy between Catheter Embolectomy Combined with Catheter-Directed Thrombolysis and Isolated Catheter-Directed Thrombolysis in the Treatment of Acute Pulmonary Embolism and Construction of a Predictive Model
DOI: 10.12677/acm.2026.1672567, PDF,   
作者: 杨 悦, 殷世武*:合肥市第二人民医院介入血管疼痛科,安徽 合肥;皖南医科大学研究生学院,安徽 芜湖;薛乐乐, 罗欣怡, 刘 奇, 曾凡祎:合肥市第二人民医院介入血管疼痛科,安徽 合肥
关键词: 急性肺栓塞导管抽栓置管溶栓危险因素预测模型Acute Pulmonary Embolism Catheter Embolus Extraction Catheter-Directed Thrombolysis Risk Factors Predictive Model
摘要: 目的:比较导管抽栓联合置管溶栓与单纯置管溶栓治疗急性肺栓塞的疗效与安全性,构建预后预测模型。方法:双向队列纳入70例患者,分为联合组(n = 33)与单纯溶栓组(n = 37)。主要疗效为复合结局(无血流动力学失代偿及死亡)。采用多因素Logistic回归构建预测模型,ROC曲线评估预测效能,并进行亚组分析与成本效果评价。结果:联合组基线病情更重(术前肺动脉压力更高,P = 0.021),但复合结局成功率显著更高(81.8% vs 54.1%, P < 0.05),成本效果比更优。模型1 (临床–影像模型)显示术前肺动脉压力(OR = 0.637)与sPESI评分(OR = 0.139)为独立预测因素(P < 0.01),两者联合预测AUC达0.886。联合治疗在sPESI 1~2分组中疗效优势显著(OR = 13.500, P = 0.018)。结论:联合治疗疗效及成本效益均优于单纯置管溶栓,术前肺动脉压力联合sPESI评分预后预测价值最优,联合治疗在sPESI 1~2分患者中优势明显。
Abstract: Objective: To compare the clinical efficacy and safety of catheter-directed thrombectomy combined with catheter-directed thrombolysis versus catheter-directed thrombolysis alone in patients with acute pulmonary embolism (APE), and to construct a prognostic prediction model. Methods: An ambidirectional cohort study enrolled 70 APE patients, divided into combination therapy group (n = 33) and thrombolysis alone group (n = 37). The primary efficacy outcome was a composite outcome (absence of hemodynamic decompensation and death). Multivariate logistic regression was used to construct prediction models. The predictive performance was assessed using ROC curves. Subgroup analysis and cost-effectiveness evaluation were also conducted. Results: The combination group had more severe baseline conditions (higher preoperative pulmonary artery pressure, P = 0.021), but achieved a significantly higher success rate of the composite outcome (81.8% vs 54.1%, P < 0.05) and a better cost-effectiveness ratio. Model 1 (clinical-imaging model) identified preoperative pulmonary artery pressure (OR = 0.637) and sPESI score (OR = 0.139) as independent predictors (P < 0.01). The combined model of these two factors achieved an AUC of 0.886. Combination therapy showed a significant efficacy advantage in the sPESI 1~2 subgroup (OR = 13.500, P = 0.018). Conclusion: The combination therapy is superior to catheter-directed thrombolysis alone in both efficacy and cost-effectiveness. The combination of preoperative pulmonary artery pressure and sPESI score provides optimal prognostic predictive value, and the advantage of combination therapy is more pronounced in patients with sPESI 1~2.
文章引用:杨悦, 薛乐乐, 罗欣怡, 刘奇, 曾凡祎, 殷世武. 导管抽栓联合置管溶栓与单纯置管溶栓治疗 急性肺栓塞的疗效对比及预测模型构建[J]. 临床医学进展, 2026, 16(7): 611-621. https://doi.org/10.12677/acm.2026.1672567

参考文献

[1] Silverstein, M.D., Heit, J.A., Mohr, D.N., Petterson, T.M., O’Fallon, W.M. and Melton, L.J. (1998) Trends in the Incidence of Deep Vein Thrombosis and Pulmonary Embolism: A 25-Year Population-Based Study. Archives of Internal Medicine, 158, 585-593. [Google Scholar] [CrossRef] [PubMed]
[2] Næss, I.A., Christiansen, S.C., Romundstad, P., Cannegieter, S.C., Rosendaal, F.R. and Hammerstrøm, J. (2007) Incidence and Mortality of Venous Thrombosis: A Population‐Based Study. Journal of Thrombosis and Haemostasis, 5, 692-699. [Google Scholar] [CrossRef] [PubMed]
[3] 肇冬梅, 章志丹, 朱然, 等. 住院肺血栓栓塞症患者32年临床流行病学分析[J]. 中国呼吸与危重监护杂志, 2006, 5(5): 345-348.
[4] 季宏志, 王萍, 高增艳, 等. 急性肺栓塞后慢性血栓栓塞性肺动脉高压研究进展[J]. 社区医学杂志, 2021, 19(18): 1144-1148.
[5] Avgerinos, E.D., Saadeddin, Z., Abou Ali, A.N., Fish, L., Toma, C., Chaer, M., et al. (2018) A Meta-Analysis of Outcomes of Catheter-Directed Thrombolysis for High-and Intermediate-Risk Pulmonary Embolism. Journal of Vascular Surgery: Venous and Lymphatic Disorders, 6, 530-540. [Google Scholar] [CrossRef] [PubMed]
[6] Sadeghipour, P., Jenab, Y., Moosavi, J., Hosseini, K., Mohebbi, B., Hosseinsabet, A., et al. (2022) Catheter-Directed Thrombolysis vs Anticoagulation in Patients with Acute Intermediate-High-Risk Pulmonary Embolism: The Canary Randomized Clinical Trial. JAMA Cardiology, 7, 1189-1197. [Google Scholar] [CrossRef] [PubMed]
[7] Lankeit, M., Jiménez, D., Kostrubiec, M., Dellas, C., Kuhnert, K., Hasenfuß, G., et al. (2014) Validation of N-Terminal Pro-Brain Natriuretic Peptide Cut-Off Values for Risk Stratification of Pulmonary Embolism. European Respiratory Journal, 43, 1669-1677. [Google Scholar] [CrossRef] [PubMed]
[8] 程显声, 何建国, 高明哲, 等. 急性肺血栓栓塞症溶栓及抗凝治疗多中心临床分析[J]. 中华内科杂志, 2002, 41(1): 6-10.
[9] 杨立恒, 代冰, 刘璠, 等. 急性肺栓塞患者远期预后随访调查及危险因素分析[J]. 中国呼吸与危重监护杂志, 2013, 12(6): 552-557.
[10] Klok, F.A., Dzikowska‐Diduch, O., Kostrubiec, M., Vliegen, H.W., Pruszczyk, P., Hasenfuß, G., et al. (2016) Derivation of a Clinical Prediction Score for Chronic Thromboembolic Pulmonary Hypertension after Acute Pulmonary Embolism. Journal of Thrombosis and Haemostasis, 14, 121-128. [Google Scholar] [CrossRef] [PubMed]
[11] Feroze, R., Arora, S., Tashtish, N., Dong, T., Jaswaney, R., Castro-Dominguez, Y., et al. (2023) Comparison of Large-Bore Thrombectomy with Catheter-Directed Thrombolysis for the Treatment of Pulmonary Embolism. Journal of the Society for Cardiovascular Angiography & Interventions, 2, Article 100453. [Google Scholar] [CrossRef] [PubMed]
[12] 刘双. 肺栓塞诊治研究进展[J]. 中华临床医师杂志(电子版), 2013, 7(15): 6792-6794.
[13] Lehnert, P., Lange, T., Møller, C., Olsen, P. and Carlsen, J. (2018) Acute Pulmonary Embolism in a National Danish Cohort: Increasing Incidence and Decreasing Mortality. Thrombosis and Haemostasis, 118, 539-546. [Google Scholar] [CrossRef] [PubMed]
[14] Schulman, S., Kearon, C., Kakkar, A.K., Mismetti, P., Schellong, S., Eriksson, H., et al. (2009) Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism. New England Journal of Medicine, 361, 2342-2352. [Google Scholar] [CrossRef] [PubMed]
[15] Borovac, J.A., Mirić, D., Bradarić Šlujo, A., Lozo, M., Pivac, V., Crnčević, N., et al. (2023) The Interventional Treatment of Intermediate-to-High Risk Acute Pulmonary Embolism at University Hospital of Split: Current Experiences and Future Directions. Cardiologia Croatica, 18, Article 81. [Google Scholar] [CrossRef
[16] Bonderman, D., Turecek, P., Jakowitsch, J., Weltermann, A., Adlbrecht, C., Schneider, B., et al. (2003) High Prevalence of Elevated Clotting Factor VIII in Chronic Thromboembolic Pulmonary Hypertension. Thrombosis and Haemostasis, 90, 372-376. [Google Scholar] [CrossRef] [PubMed]
[17] 高强, 徐巍, 王定宇, 等. 肺动脉高压介入治疗研究进展[J]. 中国介入心脏病学杂志, 2020, 28(11): 644-646.
[18] Amin, A., Naeem, M.O., Amin, L., Khaliq, S.U., Ahmad, A., Vohra, R.R., et al. (2024) Apixaban versus Low Molecular Weight Heparin in Patients with Cancer-Associated Venous Thromboembolism: A Systematic Review and Meta-Analysis. Annals of Medicine & Surgery, 86, 4675-4683. [Google Scholar] [CrossRef] [PubMed]
[19] 刘晓彤, 田春燕, 王静, 等. 低碘对比剂下CT肺动脉造影联合碘图诊断急性肺栓塞的应用价值[J]. 中国医学影像学杂志, 2025, 33(5): 525-530.
[20] Konstantinides, S., Geibel, A., Heusel, G., Heinrich, F. and Kasper, W. (2002) Heparin Plus Alteplase Compared with Heparin Alone in Patients with Submassive Pulmonary Embolism. New England Journal of Medicine, 347, 1143-1150. [Google Scholar] [CrossRef] [PubMed]
[21] Elhakim, A., Knauth, M., Elhakim, M., Böhmer, U., Patzelt, J. and Radke, P. (2022) Using a Fibrinolysis Delivery Catheter in Pulmonary Embolism Treatment for Measurement of Pulmonary Artery Hemodynamics. Advances in Respiratory Medicine, 90, 483-499. [Google Scholar] [CrossRef] [PubMed]
[22] Fish, A., Knight, E., Mutonga, M., Moulton, J., Gathagan, R., Andreca, M., et al. (2024) The Predictive Value of Qanadli and Miller Index Scores in Patients with Intermediate-High-Risk and High-Risk Pulmonary Emboli Undergoing Aspiration Thrombectomy. Journal of Vascular and Interventional Radiology, 35, 1457-1463. [Google Scholar] [CrossRef] [PubMed]